Bauer et al. analyze blood-based immune and transcriptomic markers in tuberculosis patients to identify treatment failure and recurrence. They find that specific markers reliably detect microbiological non-conversion during treatment and recurrence after therapy, providing a sputum-independent tool for patient monitoring.
- Bernadette Bauer
- Mohamed I. M. Ahmed
- Knut Lönnroth
